Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same author

Hypertrophic plaques in a patient with pulmonary adenocarcinoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Clinical Factors Associated with Genetically Confirmed Inborn Errors of Immunity in Children Presenting with Immune Dysregulation.

Clinical reviews in allergy & immunology·2026
Same author

Targeted deep sequencing identifies mosaicism in patients with immune dysregulation.

The Journal of allergy and clinical immunology·2026
Same author

A comprehensive view on r-protein binding and rRNA domain structuring during early eukaryotic ribosome formation.

Nucleic acids research·2026

相关实验视频

Updated: Jun 19, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K

在ERCC2缺乏症中,B细胞功能受损.

Raphael Rossmanith1,2,3, Kai Sauerwein1,4, Christoph B Geier1,5,6

  • 1Immunology Outpatient Clinic, Vienna, Austria.

Frontiers in immunology
|July 26, 2024
PubMed
概括
此摘要是机器生成的。

患有ERCC2突变的三二-1 (TTD1) 患者表现出抗体缺乏. 这与因ERCC2基因缺陷影响DNA修复而导致的B细胞分化和激活受损有关.

关键词:
B细胞激活激活的过程缺少DNA修复的缺陷在ERCC2中,ERCC2是ERCC2的第一个成员.这是XPD XPD.抗体缺乏症 抗体缺乏症核酸切除修复的修复原发性免疫缺陷是一种免疫缺陷.三三三三三三三三三

更多相关视频

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.2K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.6K

相关实验视频

Last Updated: Jun 19, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.2K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.6K

科学领域:

  • 遗传学和免疫学 遗传学和免疫学
  • DNA 修复机制的修复机制
  • 细胞生物学 细胞生物学

背景情况:

  • 三二-1 (TTD1) 是一种由ERCC2基因突变引起的自体逆向性疾病,ERCC2基因是参与转录和DNA修复的TFIIH复合物的组成部分.
  • 许多TTD1患者对感染的易感性增加,但潜在的免疫缺陷机制尚不清楚.

研究的目的:

  • 在TTD1患者中进行全面的分子和免疫学评估.
  • 阐明TTD1.1中免疫缺陷的细胞和分子基础.

主要方法:

  • 用于细胞免疫表型的多色流细胞计.
  • 紫外线辐射测试以评估DNA修复效率.
  • 通过mRNA测序对B细胞激活,增殖和基因表达的分析.

主要成果:

  • TTD1患者表现出低血和降低抗体反应.
  • 在UV照射后,B细胞显示DNA损伤积累 (γ-H2AX),增殖受损,活力降低.
  • 基因表达分析揭示了关键B细胞发育和激活基因的下调,减少了原始和过渡性B细胞种群.

结论:

  • 新的ERCC2突变被证实是致病性的.
  • 由于异常的B细胞分化,ERCC2缺乏与抗体缺乏有关.
  • 由于ERCC2缺陷导致的B细胞激活和转录受损是观察到的免疫缺陷的基础.